These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 1532436)

  • 1. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
    Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
    Zhao S; Li X; Wang Z
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(3):299-301. PubMed ID: 10681765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in high density lipoproteins in peripheral vascular disease].
    Pedro-Botet J; Sentí M; Nogués X; Rubiés-Prat J; Vidal-Barraquer F
    Med Clin (Barc); 1991 Apr; 96(13):493-5. PubMed ID: 2051792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
    Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular disease-related serum lipid parameters in a Hungarian subpopulation].
    Szépvölgyi J; Kravják BE; Bíró L; Nagy K; Bíró G; Antal M
    Orv Hetil; 1997 Aug; 138(32):2005-8. PubMed ID: 9297170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between incidence of lipoprotein(a) positivity and coronary heart disease.
    Vashisht S; Wasir H; Srivastava LM
    Indian Heart J; 1992; 44(4):223-6. PubMed ID: 1289218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoprotein cholesterol low serum level as the only risk factor in male patients with coronary heart disease.
    Alessandri C; Basili S; Peverini F; Barsi R; Paradiso M; Coppotelli L; Violi F; Cordova C
    Clin Ter; 1992 Aug; 141(8):109-14. PubMed ID: 1395453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipoprotein Lp(a) in obesity.
    Donatelli M; Verga S; Vaccaro M; Russo V; Bucalo ML; Scarpinato A
    Diabetes Res; 1992; 20(4):127-31. PubMed ID: 1345006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of cholesterol and other lipids from a lipid nanoemulsion to high-density lipoprotein in heart transplant patients.
    Puk CG; Bocchi EA; Lo Prete AC; Ferreira SM; Stolf NA; Maranhão RC
    J Heart Lung Transplant; 2009 Oct; 28(10):1075-80. PubMed ID: 19782290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups.
    Konerman M; Kulkarni K; Toth PP; Jones SR
    J Clin Lipidol; 2012; 6(4):368-73. PubMed ID: 22836074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.